{{Rsnum
|rsid=2782931
|Gene=SUSD1
|Chromosome=9
|position=112087910
|Orientation=plus
|GMAF=0.2576
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SUSD1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 43.4 | 47.8 | 8.8
| HCB | 55.9 | 41.2 | 2.9
| JPT | 58.4 | 35.4 | 6.2
| YRI | 73.1 | 26.9 | 0.0
| ASW | 59.6 | 38.6 | 1.8
| CHB | 55.9 | 41.2 | 2.9
| CHD | 60.6 | 34.9 | 4.6
| GIH | 68.3 | 29.7 | 2.0
| LWK | 73.6 | 23.6 | 2.7
| MEX | 70.2 | 22.8 | 7.0
| MKK | 55.8 | 39.1 | 5.1
| TSI | 47.1 | 43.1 | 9.8
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs2782931
|PubMedID=17362836
|Condition=Amyotrophic lateral sclerosis
|Gene=SUSD1
|Risk Allele=
|pValue=6.00E-006
|OR=1.11
|95CI=0.91-1.43
}}

{{PharmGKB
|RSID=rs2782931
|Name_s=
|Gene_s=SUSD1
|Feature=
|Evidence=PubMed ID:17362836; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data (Initial Sample Size: 276 cases, 276 controls; Replication Sample Size: NR). This variant is associated with Amyotrophic lateral sclerosis.
|Drugs=
|Drug Classes=
|Diseases=Amyotrophic Lateral Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356533
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2782931
|overall_frequency_n=33
|overall_frequency_d=128
|overall_frequency=0.257812
|n_genomes=26
|n_genomes_annotated=0
|n_haplomes=30
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}